François de Mets
Principal Scientist GlaxoSmithKline
Seminars
Wednesday 25th March 2026
From Template to Transcript: Impact of DNA Product Quality on mRNA Therapeutic Outcomes
4:00 pm
- Designing DNA vectors to influence double-stranded RNA formation and improve downstream process performance
- Engineering a plasmid that impacts polyA tail length to maximize product quality
- Understanding the importance of pDNA as a starting material on mRNA product quality to inform plasmid design
